A digital intervention using the Apple Watch helped people on Medicaid better control their asthma, illustrating the ...

Elevance Health (ELV) just surged a massive 191% in trading volume, turning heads in the stock market. On July 22, 2025, the ...

The stock's rise snapped a three-day losing streak.

Argus has downgraded Elevance Health to hold from buy citing pressure on profit margins due to higher medical cost trends in its ACA marketplace and Medicaid businesses.

We recently published These 10 Stocks Fell Hard. Are You Holding Any? Elevance Health, Inc. (NYSE:ELV) is one of this week’s ...

Shares of Elevance Health Inc. (NYSE:ELV) dropped to a new 52-week low of $275.60, reflecting a turbulent year for the ...

Elevance cut its annual profit forecast and missed Wall Street estimates for quarterly earnings on Thursday, the latest U.S.

Elevance’s membership declined slightly from the first quarter, with drops in Medicaid and fewer people purchasing Affordable ...

The Indianapolis-based company said it had net income of $7.72 per share. Earnings, adjusted for one-time gains and costs, came to $8.84 per share. The results did not meet Wall Street expectations.

Elevance Health is scheduled to report earnings tomorrow morning, and investors are already sharpening their pencils. Last ...

Shares of health insurance provider Elevance Health (NYSE:EVH) fell 9.9% in the afternoon session after peer, Centene pulled its full-year financial guidance, triggering a sector-wide sell-off.

Managed care organizations like Elevance Health benefit from scale, strong network effects, and high returns on equity. Read why ELV stock is a Buy.